2022 Hyundai Palisade SEL
3.8 L • 6 • 291 hp • FWD • AT
KM8R44HE7NU347372
Sales history: 1
Highlights
Condition
Engine starts
Seller
Unknown
Key included
Yes
Docs
Good
History
1 record
Drive
3.8 L • 6 • 291 hp • FWD • AT
Odometer
39,913 mi ≈ 64,234 km
Primary damage
Front end
Secondary damage
Undercarriage
Docs
Salvage >75% Damage
Extra
Auction
VIN
KM8R44HE7NU347372
Lot number
84748804
Copart
Sale status
Sold
Location
Baltimore East, MD
Description
Fuel type
Gasoline
Body color
Black
Body type
SUV
Generation
LX2
Trim
SEL
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Hyundai models
2022 Hyundai Palisade SEL • 3.8 L • 6 cyl • 291 hp • FWD • Automatic • Copart Lot: 84748804 • VIN: KM8R44HE7NU347372
Find out more about this 2022 Hyundai Palisade SEL, available at the Copart salvage car auction as lot 84748804 in Baltimore East, MD. This car has Front end main damage. It is listed with Engine starts start condition code. Odometer shows 39,913 mi. This Black Hyundai Palisade SUV is equipped with Gasoline 3.8 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for KM8R44HE7NU347372 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
